Poor response to desmopressin acetate (DDAVP) in children with Hermansky-Pudlak syndrome
- PMID: 15368543
- DOI: 10.1002/pbc.20210
Poor response to desmopressin acetate (DDAVP) in children with Hermansky-Pudlak syndrome
Abstract
Background: Hermansky-Pudlak syndrome (HPS) is a common genetic disorder in Puerto Rico. In children with HPS, bleeding is the most disturbing and incapacitating problem. Desmopressin (1-deamino-8-D-arginine vasopressin, (DDAVP)) has been recommended in the management of bleeding disorders characterized by platelet dysfunction, such as HPS.
Methods: Nineteen pediatric Puerto Rican patients with HPS and prolonged bleeding time (BT) were tested for response to administration of DDAVP.
Results: Baseline BT was abnormal in 18 (95%) of the patients. The BT following DDAVP administration improved in two cases (11%): one from 7.2 to 5.6 min and the other from 8 to 6 min (Tables II and III). BT measurements remained very prolonged (>15 min) in 17 (89%) of the patients. Patients with the HPS 1 gene mutation had a statistically significant correlation with the poor response following DDAVP (P = 0.03).
Conclusions: DDAVP seldom improves the BT of Puerto Rican children with HPS. Response to DDAVP should be determined individually and platelet transfusion should remain the treatment of choice for a major bleeding episode or surgical procedure.
(c) 2004 Wiley-Liss, Inc.
Similar articles
-
Two successful vaginal births after cesarean section in a patient with Hermansky-Pudlak syndrome who was treated with 1-deamino-8-arginine-vasopression during labor.Mil Med. 2008 Oct;173(10):1048-9. doi: 10.7205/milmed.173.10.1048. Mil Med. 2008. PMID: 19160629
-
Successful bilateral lung transplantation for pulmonary fibrosis associated with the Hermansky-Pudlak syndrome.J Heart Lung Transplant. 2005 Oct;24(10):1697-9. doi: 10.1016/j.healun.2004.11.015. J Heart Lung Transplant. 2005. PMID: 16210149
-
Mechanisms of platelet dysfunction and response to DDAVP in patients with congenital platelet function defects. A double-blind placebo-controlled trial.Thromb Haemost. 1995 Oct;74(4):1071-8. Thromb Haemost. 1995. PMID: 8560416 Clinical Trial.
-
Desmopressin (DDAVP) in the management of patients with congenital bleeding disorders.Haemophilia. 2014 Mar;20(2):158-67. doi: 10.1111/hae.12254. Epub 2013 Aug 12. Haemophilia. 2014. PMID: 23937614 Review.
-
Desmopressin in inherited disorders of platelet function.Haemophilia. 2008 Jan;14 Suppl 1:31-9. doi: 10.1111/j.1365-2516.2007.01607.x. Haemophilia. 2008. PMID: 18173692 Review.
Cited by
-
Clinical management and outcomes of patients with Hermansky-Pudlak syndrome pulmonary fibrosis evaluated for lung transplantation.PLoS One. 2018 Mar 16;13(3):e0194193. doi: 10.1371/journal.pone.0194193. eCollection 2018. PLoS One. 2018. PMID: 29547626 Free PMC article. Clinical Trial.
-
Genetic variants associated with Hermansky-Pudlak syndrome.Platelets. 2020 May 18;31(4):544-547. doi: 10.1080/09537104.2019.1663810. Epub 2019 Sep 5. Platelets. 2020. PMID: 32436471 Free PMC article.
-
Pharmacogenetics of healthy volunteers in Puerto Rico.Drug Metab Pers Ther. 2015 Dec;30(4):239-49. doi: 10.1515/dmpt-2015-0021. Drug Metab Pers Ther. 2015. PMID: 26501165 Free PMC article. Review.
-
BLOC-2 subunit HPS6 deficiency affects the tubulation and secretion of von Willebrand factor from mouse endothelial cells.J Genet Genomics. 2016 Dec 20;43(12):686-693. doi: 10.1016/j.jgg.2016.09.007. Epub 2016 Oct 21. J Genet Genomics. 2016. PMID: 27889498 Free PMC article.
-
Defective AP-3-dependent VAMP8 trafficking impairs Weibel-Palade body exocytosis in Hermansky-Pudlak Syndrome type 2 blood outgrowth endothelial cells.Haematologica. 2019 Oct;104(10):2091-2099. doi: 10.3324/haematol.2018.207787. Epub 2019 Jan 10. Haematologica. 2019. PMID: 30630984 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
